clofibrate has been researched along with desoxycorticosterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Blanton, A; Fidelis, P; Newaz, M; Oyekan, A | 1 |
| Chang, HH; Dong, Z; Huang, H; Luo, P; Wang, CY; Wang, MH; Yang, T; Zhou, Y | 1 |
1 review(s) available for clofibrate and desoxycorticosterone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for clofibrate and desoxycorticosterone
| Article | Year |
|---|---|
NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects.
Topics: Animals; Blood Pressure; Clofibrate; Desoxycorticosterone; Endothelin-1; Free Radicals; Hypertension; Lipid Peroxides; Male; Mice; Mice, Knockout; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; PPAR alpha; Rats; Rats, Sprague-Dawley; Systole | 2005 |
Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.
Topics: Animals; Blood Pressure; Clofibrate; Cytochrome P-450 CYP4A; Desoxycorticosterone; Hydroxyeicosatetraenoic Acids; Hypernatremia; Hypertension; Kidney Tubules; Mice; Mice, Knockout; PPAR alpha; Sodium Chloride | 2008 |